MedTrace Logo

Outcomes of Patient Blood Management in Patients Undergoing Major Surgery

NCT06553833 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25979

Last updated 2025-04-20

No results posted yet for this study

Summary

The goal of this observational study is to compare patients who underwent major surgery and who were eligible to receive different management of their red blood count, namely, allogeneic transfusions with or without patient blood management, or blood management alone. Its main questions it aims to answer are:

Which group of patients dies more frequently: Patients who receive patient blood management only, patients who receive patient blood management and transfusions where indicated, or patients who are eligible to receive transfusions only.

Among these groups: which group of patients has more complications during hospital stay? Patients will either receive patients blood management, which is the management of anemia, bleeding and coagulation problems, will receive transfusions, that is, blood from other people, or a mix of both.

Conditions

  • Major Surgery

Interventions

BIOLOGICAL

Allogeneic transfusion

Anemia is treated by administering donor red cells, and bleeding or coagulopathy by plasma, platelets or other donor blood products.

OTHER

Patient Blood Management

PBM is a strategy to manage the participants own blood. Its focus is on anemia, bleeding and coagulation management (using predominantly pharmaceutical and technological means).

Sponsors & Collaborators

  • HELIOS Hospital, Erfurt, Germany

    collaborator OTHER

  • Matthias Lucas

    collaborator UNKNOWN

  • Helios Klinik Gotha/Ohrdruf

    lead OTHER

Principal Investigators

  • Petra Seeber · HELIOS Klinikum Gotha

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-01-01
Completion
2025-01-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06553833 on ClinicalTrials.gov